Investors / United States / Treo Ventures
Treo Ventures
Venture capital · Santa Clara, CA, United States · North America
Treo Ventures is a venture capital firm established in 2018 that focuses on medical device and digital health innovation targeting large unmet clinical needs. It invests in both early-stage companies with some proof of concept and later-stage companies with strong clinical data seeking regulatory approval, and it also invests in opportunities generated by NuXcel, its own medical device accelerator.
Invests inHealthcare & Biotech
In its own wordsmedical devicesdigital healthneuromodulationplatform technologyhealthcaremedtech
Your fit with Treo Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsTreo Ventures lists 11 checked portfolio companies on its own site and is named in 1 funding round, 1 of them as lead. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 91% of its companies are based in United States. It invests most often alongside Hatteras Venture Partners, U.S. Venture Partners and ABS Ventures.
Counts come from funding rounds that name Treo Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Treo Ventures' whole history. Rounds on record name 1 company; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 75th | 9% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Hatteras Venture Partners | 3 |
| U.S. Venture Partners | 2 |
| ABS Ventures | 1 |
| Amzak Health | 1 |
| Angelini Ventures | 1 |
| Aperture Venture Partners | 1 |
| Asahi Kasei Ventures | 1 |
| Blue Venture Funds | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1091%
- No longer answers00%
- Points to another company19%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Hatteras Venture Partners
Compare Treo Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Treo Ventures| Date | Company | Stage |
|---|---|---|
| 8 Apr 2025 | Series A Led |
Round details for Treo Ventures
Amounts, full round histories and every co-investor in Treo Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Avivomed is developing neuromodulation therapies for patients suffering from obstructive sleep apnea | Healthcare & Biotech | Portfolio page | ||
| CVRx develops and implants a device to treat heart failure | Healthcare & Biotech | Portfolio page | ||
| Hyalex Orthopaedics develops orthopaedic materials and systems to restore damaged joint surfaces at the time of surgery. | Healthcare & Biotech | Portfolio page | ||
| InterVene develops medical devices to treat venous obstructions and related conditions. | Healthcare & Biotech | Portfolio page | ||
| iVEAcare develops innovative neuromodulation technologies for individuals living with epilepsy | Healthcare & Biotech | Portfolio page | ||
| NeoChord develops and sells a medical device for mitral valve repair | Healthcare & Biotech | Portfolio page | ||
| Neuspera Medical develops implantable medical devices for treating urinary urge incontinence and overactive bladder | Healthcare & Biotech | Portfolio page | ||
| Noctrix Health develops wearable therapeutics for managing chronic neurological disorders. | Healthcare & Biotech | Portfolio page | ||
| NuXcel develops innovative medical device solutions to serve large unmet clinical needs. | Healthcare & Biotech | Portfolio page | ||
| SecondWave Systems is developing a noninvasive, wearable ultrasound stimulation platform for treating diseases. | Healthcare & Biotech | Apr 2025Series A | Page + round | |
| ShiraTronics develops a neuromodulation device to treat chronic migraine | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- treovp.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 8 Apr 2025
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Treo Ventures' profile as data
Pull Treo Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/treovp.com
# also
GET /v1/firms/treovp.com/portfolio
GET /v1/firms/treovp.com/coinvestors
GET /v1/firms/treovp.com/news